Table II.
Treatment delivery.
| Characteristics | Arm without CTV | Arm with CTV | P-value |
|---|---|---|---|
| No. of patients | 55 | 50 | |
| Treatment schedule, n (%) | |||
| Induction chemo | 3 (5.5) | 6 (12.0) | 0.724 |
| Concurrent chemo | 12 (21.8) | 10 (20.0) | |
| Induction + concurrent adjuvant chemo | 20 (36.4) | 19 (38.0) | |
| Induction + concurrent chemo | 6 (10.9) | 5 (10.0) | |
| Concurrent adjuvant | 10 (18.2) | 5 (10.0) | |
| RT alone | 4 (7.3) | 5 (10.0) | |
| Induction chemo (cycles), n (%) | |||
| 0 | 26 (47.3) | 20 (40.0) | 0.828 |
| 1 | 4 (7.3) | 3 (6.0) | |
| 2 | 16 (29.1) | 16 (32.0) | |
| ≥3 | 9 (16.4) | 11 (22.0) | |
| Concurrent chemo (cycles), n (%) | |||
| 0 | 37 (67.3) | 35 (70.0) | 0.517 |
| 1 | 0 (0) | 1 (2.0) | |
| 2 | 18 (32.7) | 14 (28.0) | |
| Adjuvant chemo (cycles), n (%) | |||
| 0 | 25 (45.5) | 26 (52.0) | 0.117 |
| 1 | 7 (12.7) | 1 (2.0) | |
| 2 | 23 (41.8) | 23 (46.0) |
CTV, clinical target volume; chemo, chemotherapy; RT, radiation therapy.